載入...
Systematic screening of generic drugs for progressive multiple sclerosis identifies clomipramine as a promising therapeutic
The treatment of progressive multiple sclerosis (MS) is unsatisfactory. One reason is that the drivers of disease, which include iron-mediated neurotoxicity, lymphocyte activity, and oxidative stress, are not simultaneously targeted. Here we present a systematic screen to identify generic, orally av...
Na minha lista:
| 發表在: | Nat Commun |
|---|---|
| Main Authors: | , , , , , , , , , |
| 格式: | Artigo |
| 語言: | Inglês |
| 出版: |
Nature Publishing Group UK
2017
|
| 主題: | |
| 在線閱讀: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5736601/ https://ncbi.nlm.nih.gov/pubmed/29259169 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/s41467-017-02119-6 |
| 標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|